meningitis

(redirected from Menactra)
Also found in: Thesaurus, Medical, Encyclopedia.

men·in·gi·tis

 (mĕn′ĭn-jī′tĭs)
n.
Inflammation of the meninges of the brain and the spinal cord, most often caused by a bacterial or viral infection and characterized by fever, vomiting, intense headache, and stiff neck.

men′in·git′ic (-jĭt′ĭk) adj.

meningitis

(ˌmɛnɪnˈdʒaɪtɪs)
n
(Pathology) inflammation of the membranes that surround the brain or spinal cord, caused by infection
meningitic adj

men•in•gi•tis

(ˌmɛn ɪnˈdʒaɪ tɪs)

n.
inflammation of the meninges, esp. of the pia mater and arachnoid, caused by a bacterial or viral infection and characterized by high fever, severe headache, and stiff neck or back muscles.
[1820–30]
men`in•git′ic (-ˈdʒɪt ɪk) adj.

men·in·gi·tis

(mĕn′ĭn-jī′tĭs)
Inflammation of the membranes (meninges) that enclose the brain and spinal cord, usually resulting from a bacterial infection.

meningitis

Inflammation of the linings of the brain (meninges) usually caused by a virus.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.meningitis - infectious disease characterized by inflammation of the meninges (the tissues that surround the brain or spinal cord) usually caused by a bacterial infectionmeningitis - infectious disease characterized by inflammation of the meninges (the tissues that surround the brain or spinal cord) usually caused by a bacterial infection; symptoms include headache and stiff neck and fever and nausea
choriomeningitis - a cerebral meningitis with cellular infiltration of the meninges
infectious disease - a disease transmitted only by a specific kind of contact
brain fever, cerebrospinal fever, cerebrospinal meningitis, epidemic meningitis - meningitis caused by bacteria and often fatal
cerebromeningitis, encephalomeningitis, meningoencephalitis - inflammation of the brain and spinal cord and their meninges
leptomeningitis - inflammation of the leptomeninges
Translations
إلْتِهاب السَّحاياالْتِهَابُ الْسَّحَايَا
meningitidazánět mozkových blan
meningitis
aivokalvontulehdus
meningitis
agyhártyagyulladás
heilahimnubólga
髄膜炎
뇌수막염수막염
meningitas
meningīts
zápal mozgových blán
hjärnhinneinflammation
เยื่อหุ้มสมองอักเสบ
viêm màng não

meningitis

[ˌmenɪnˈdʒaɪtɪs] Nmeningitis f inv

meningitis

[ˌmɛnɪndˈʒaɪtɪs] nméningite f

meningitis

meningitis

[ˌmɛnɪnˈdʒaɪtɪs] nmeningite f

meningitis

(meninˈdʒaitis) noun
a serious disease in which there is inflammation of the membranes round the brain or spinal cord.

meningitis

الْتِهَابُ الْسَّحَايَا meningitida meningitis Hirnhautentzündung μηνιγγίτιδα meningitis aivokalvontulehdus méningite meningitis meningite 髄膜炎 수막염 meningitis hjernehinnebetennelse zapalenie opon mózgowych meningite менингит hjärnhinneinflammation เยื่อหุ้มสมองอักเสบ menenjit viêm màng não 脑膜炎

men·in·gi·tis

n. meningitis, infl. de las meninges cerebrales o espinales;
cryptococcal ______ criptocócica;
meningcoccal ______ meningocócica;
viral ______ viral.

meningitis

n meningitis f
References in periodicals archive ?
These vaccines include Prevnar/ Prevnar 13, Gardasil/ Gardasil 9, Vaxigrip, Fluzone, Flublok, Varivax, Proquad, Menactra, Fluarix/ FluLaval, Pneumovax 23, Havrix/ Twinrix/ Engerix-B, Priorix, Priorix Tetra, Varilrix, M-M-R II, Adacel, Boostrix, Menveo, Bexsero, Cervarix, Shingrix, Trumenba, Rotateq, Pentacel, Pentaxim, Imovax, Hexaxim, Zostavax, Rotarix, Sunflorix, Pediarix, Infanrix, Ticovac, Biken Ha, Tetrabik, Mearubik, Varicella (MTP), Jebik V, Flumist/ Fluenz, Bio Thrax, Dukoral, In Live, Ixiaro, HeaLive, In Live, BiLive, EasySix, Imvamune, and Anflu.
Vaccines sales were up 21% to 873 million [euro], reflecting growth of Pentaxim in China and Menactra in Emerging Markets.
A second vaccine for meningococcal disease meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135 (Menactra) is under study by the Menactra Vaccine Pregnancy Registry (800-822-2463).
Browse Meningococcal Vaccines Market by Meningococcal Combination Vaccines (Bexsero, Trumenba, MenHibrix, Menitorix); Meningococcal Conjugate Vaccines (Menactra, MenAfriVac, Meningitec, Menjugate, Menveo, NeisVac-C, Nimenrix, NmVac4-DT); and Meningococcal Polysaccharide Vaccine (Bi Meningo, Mencevax, Menomune, NmVac4, Quadri Meningo) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/meningococcal-vaccines-market/
Two meningococcal conjugate vaccines are available in the United States: Menactra, (Sanofi Pasteur), licensed for use in individuals ages 9 months to 55 years; and Menveo (GlaxoSmithKline), licensed for use in individuals ages 2 months to 55 years.
In individuals with anatomic or functional asplenia, meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV4-D, Menactra) should be given 4 weeks after the last dose of the pneumococcal conjugate vaccine (PCV13).
meningitidis bacteria that cause meningococcal disease (A, C, W, and Y): They are the meningococcal polysaccharide vaccine (Menomune) and the meningococcal conjugate vaccine (Menactra and Menveo).
Approved in the US in 1981 and Australia in 1994, Menomune was among the first available vaccines against meningococcal disease and was the standard of care in the US until the introduction of Menactra in 2005.
Currently, tetravalent conjugate vaccines, such as Sanofi's Menactra and Novartis' Menveo, account for the vast majority of global sales, with the US adolescent market being the key target segment.
M2 PHARMA-December 4, 2012-Sanofi Pasteur Canada announces approval by Health Canada of Menactra Meningococcal Conjugate Vaccine for infants from nine months(C)2012 M2 COMMUNICATIONS
M2 EQUITYBITES-December 4, 2012-Sanofi Pasteur Canada announces approval by Health Canada of Menactra Meningococcal Conjugate Vaccine for infants from nine months(C)2012 M2 COMMUNICATIONS http://www.m2.com
Food and Drug Administration (FDA) has approved the use of Sanofi Pasteur's bacterial meningitis vaccine Menactra in children as young as 9 months.